Petrus Bekker is Chief Medical Officer at ChemoCentryx, Inc. (CCXI). They have made 13 open-market trades across 1 company since 2012, most recently 2017-07-13.
CIK 0001340652
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CCXI | 59,839 | $672K |
Shares reported on the most recent Form 4, priced at the 2017-07-13 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CCXI | SELL | 2017-07-13 | 2017-07-13 | $10.19 | $124K | -2.2% | -29.7% | -24.6% |
| CCXI | SELL | 2017-07-12 | 2017-07-13 | $9.92 | $92K | -2.2% | -29.7% | -24.6% |
| CCXI | SELL | 2017-07-11 | 2017-07-13 | $9.78 | $293K | -2.2% | -29.7% | -24.6% |
| CCXI | SELL | 2017-07-11 | 2017-07-13 | $9.97 | $971K | -2.2% | -29.7% | -24.6% |
| CCXI | SELL | 2017-07-07 | 2017-07-10 | $9.30 | $367K | +8.0% | -15.4% | -13.0% |
| CCXI | SELL | 2017-06-30 | 2017-06-30 | $9.23 | $277K | +13.1% | +10.1% | -18.3% |
| CCXI | SELL | 2017-06-29 | 2017-06-30 | $9.11 | $50K | +13.1% | +10.1% | -18.3% |
| CCXI | SELL | 2017-06-28 | 2017-06-30 | $9.16 | $760K | +13.1% | +10.1% | -18.3% |
| CCXI | SELL | 2017-06-28 | 2017-06-30 | $9.12 | $274K | +13.1% | +10.1% | -18.3% |
| CCXI | SELL | 2016-12-16 | 2016-12-20 | $8.69 | $58K | -5.3% | -4.6% | -7.3% |
| CCXI | SELL | 2016-12-16 | 2016-12-20 | $8.72 | $134K | -5.3% | -4.6% | -7.3% |
| CCXI | SELL | 2016-12-05 | 2016-12-07 | $8.50 | $255K | +11.0% | +4.0% | -14.2% |
| CCXI | SELL · 10b5-1 | 2016-11-22 | 2016-11-23 | $8.30 | $10K | -0.1% | +0.2% | -11.8% |
| CCXI | SELL | 2016-11-09 | 2016-11-14 | $8.00 | $267K | +6.4% | +3.7% | -13.9% |
| CCXI | SELL · 10b5-1 | 2013-08-07 | 2013-08-09 | $13.26 | $66K | -48.7% | -9.1% | -9.1% |
| CCXI | SELL · 10b5-1 | 2013-07-17 | 2013-07-19 | $14.54 | $145K | -48.7% | -9.1% | -9.1% |
| CCXI | SELL · 10b5-1 | 2013-06-25 | 2013-06-27 | $14.00 | $70K | -48.7% | -9.1% | -9.1% |
| CCXI | SELL · 10b5-1 | 2013-06-17 | 2013-06-19 | $12.00 | $60K | -48.7% | -9.1% | -9.1% |
| CCXI | SELL · 10b5-1 | 2013-05-23 | 2013-05-28 | $14.00 | $67K | -48.7% | -9.1% | -9.1% |
| CCXI | SELL · 10b5-1 | 2013-05-20 | 2013-05-22 | $14.00 | $3K | -48.7% | -9.1% | -9.1% |
| CCXI | SELL · 10b5-1 | 2013-05-15 | 2013-05-17 | $13.97 | $210K | -48.7% | -9.1% | -9.1% |
| CCXI | SELL · 10b5-1 | 2013-04-11 | 2013-04-12 | $14.03 | $56K | -48.7% | -9.1% | -9.1% |
| CCXI | SELL · 10b5-1 | 2013-04-01 | 2013-04-02 | $14.00 | $14K | -48.7% | -9.1% | -9.1% |
| CCXI | SELL · 10b5-1 | 2013-03-15 | 2013-03-19 | $13.90 | $193K | -48.7% | -9.1% | -9.1% |
| CCXI | SELL · 10b5-1 | 2013-03-12 | 2013-03-14 | $14.00 | $117K | -48.7% | -9.1% | -9.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.